Clinical studies of the drug, called an integrase inhibitor, showed that, when combined with two existing drugs, it reduced the virus to undetectable levels in nearly 100 percent of HIV patients prescribed a drug regimen for the first time, The Los Angeles Times said Tuesday. It had a similar effect in 72 percent of salvage therapy patients, who take a mixture of existing medications aimed at stalling the virus until new drugs appear.
New AIDS drug shows 'phenomenal' results from PhysOrg.com
AIDS researchers said a new drug shows promise for inhibiting the HIV virus in patients new to treatment or those currently taking a drug cocktail.
[...]
No comments:
Post a Comment
We Appreciate Your Feedback